microRNA in Human Disease & Development
Royal Sonesta Hotel

Cambridge, Massachusetts


   The role of microRNA in regulating mammalian development and disease
   is now well established. miRNAs represent a novel class of targets for
   therapeutic and diagnostic development, currently not fully exploited
   by the pharmaceutical and biotechnology industries. Cambridge
   Healthtech Institute’s Sixth Annual microRNA in Human Disease and
   Development meeting is specifically designed to address the role of
   miRNA in human development and disease, and to explore the impact of
   this new research for drug and diagnostic development. The meeting
   will cover progress in identifying human miRNA, technologies used for
   miRNA profiling, and the latest research in linking miRNA to human
   disease. Opportunities for using miRNA as diagnostic biomarkers and a
   novel class of targets for therapeutic development will be explored.

Schedule of Presentations:

Monday, March 22, 2010
Tuesday, March 23, 2010
Wednesday, March 24, 2010
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.